脑部放疗，上午比下午敏感许多！4 n% ^0 E9 j' w: d9 K5 x( b
; `# ^3 `7 K3 F7 \0 A+ G7 }) @+ R2 [
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
' g3 N9 p5 h4 y. D9 oGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?: ~) q+ d% Z2 o
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.8 I- E9 V Z) V* y! O! n- W
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
) P: w z. x! Y4 F& _4 L
' o- y7 c$ ^+ Y8 k& nAbstract$ L; g: M$ K& z: m
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
3 J, u7 r: {7 ? v X, I0 O+ l8 p, t3 O9 ?
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.1 c/ O2 ?0 P: R3 c5 V7 ?! O
# E! v, h/ }) N3 ?% F! lRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).: F/ y- r6 m! s/ _4 Z1 w7 ^
2 D, d. j# }- V
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.! x% c, u( z0 H$ P# {( m* W% J, l- Y
) k% z0 D% I+ g5 {8 ~7 `' u
|
3 y4 o, a* i0 Y7 V. N, I9 z
显身卡
